Authors : Saengboon S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/mortality ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods

Source: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3237-3245.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD.

Authors : Etra A; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.; El Jurdi N

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/blood ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/diagnosis ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology

Source: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3284-3292.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.

Authors : Rashidi A; Clinical Research Division, Fred Hutchinson Cancer Center; and Division of Oncology, University of Washington, Seattle, Washington.

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/microbiology ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/immunology ; Fecal Microbiota Transplantation*

Source: Cancer research communications [Cancer Res Commun] 2024 Jun 10; Vol. 4 (6), pp. 1454-1466.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list

Academic Journal

MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT.

Authors : Siemaszko J; Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.; Dratwa M

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/genetics ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology ; Cytomegalovirus Infections*/Cytomegalovirus Infections*/Cytomegalovirus Infections*/genetics

Source: Archivum immunologiae et therapiae experimentalis [Arch Immunol Ther Exp (Warsz)] 2024 Jun 07; Vol. 72 (1). Date of Electronic Publication: 2024 Jun 07 (Print Publication: Publisher: Sciendo Country of Publication: Poland NLM ID: 0114365 Publication Model: eCollection Cited Medium: Internet ISSN: 1661-4917

Record details

Read More Add to Saved list

Academic Journal

Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation.

Authors : Nakamae H; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Cyclophosphamide*/Cyclophosphamide*/Cyclophosphamide*/therapeutic use ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/prevention & control

Source: Frontiers in immunology [Front Immunol] 2024 Jun 06; Vol. 15, pp. 1403936. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease.

Authors : Miyazawa M; Department of Gastroenterology, Kanazawa University Hospital, Japan.; Yanagi M

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Hypertension, Portal*/Hypertension, Portal*/Hypertension, Portal*/etiology ; Hypertension, Portal*/Hypertension, Portal*/Hypertension, Portal*/diagnosis

Source: Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jun 01; Vol. 63 (11), pp. 1563-1568. Date of Electronic Publication: 2023 Oct 13.Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list

Academic Journal

Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT.

Authors : Sanz J; Hematology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.; CIBERONC, Carlos III Health Institute, Madrid, Spain.

Subjects: Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/mortality ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods

Source: Blood advances [Blood Adv] 2024 May 28; Vol. 8 (10), pp. 2332-2341.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study.

Authors : Gavriilaki E; 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, 54643 Thessaloniki, Greece.; Christoforidi M

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/microbiology ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects

Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 26; Vol. 25 (11). Date of Electronic Publication: 2024 May 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list

Academic Journal

Breaking barriers: supporting hematopoietic stem cell transplant program through collaborative radiation therapy service from a physically distant center.

Authors : Pandit S; Department of Clinical Oncology, Kathmandu Cancer Center, Tathali, Bhaktapur, Nepal. .; Sapkota S

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Transplantation Conditioning*/Transplantation Conditioning*/Transplantation Conditioning*/methods

Source: Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2024 May 20; Vol. 36 (1), pp. 17. Date of Electronic Publication: 2024 May 20.Publisher: SpringerOpen Country of Publication: England NLM ID: 9424566 Publication Model: Electronic Cited Medium: Internet ISSN: 2589-0409

Record details

Read More Add to Saved list

Academic Journal

The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation.

Authors : Hadjis AD; Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, United States.; McCurdy SR

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods

Source: Frontiers in immunology [Front Immunol] 2024 May 16; Vol. 15, pp. 1358668. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list